Live Breaking News & Updates on Eupraxia Pharmaceuticals

Stay updated with breaking news from Eupraxia pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eupraxia Pharmaceuticals Confirms Board and Plans

Eupraxia Pharmaceuticals (TSE:EPRX) has released an update. Eupraxia Pharmaceuticals Inc. has successfully concluded its Annual General and Special. ....

Eupraxia-pharmaceuticals-inc , Eupraxia-pharmaceuticals , Annual-general ,

Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Shares Down 1.1%

Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) shares dropped 1.1% during mid-day trading on Wednesday . The stock traded as low as C$2.78 and last traded at C$2.78. Approximately 6,065 shares changed hands during trading, a decline of 18% from the average daily volume of 7,410 shares. The stock had previously closed at C$2.81. […] ....

Eupraxia-pharmaceuticals-inc , News-ratings-for-eupraxia-pharmaceuticals-daily , Eupraxia-pharmaceuticals , Eupraxia-pharmaceuticals-trading-down , Eupraxia-pharmaceuticals-company-profile , Get-free-report , Pharmaceuticals-trading-down , Pharmaceuticals-inc , Eupraxia-pharmaceuticals-daily ,

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Raised to Strong-Buy at Raymond James

Raymond James upgraded shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) to a strong-buy rating in a report published on Wednesday morning, Zacks.com reports. Eupraxia Pharmaceuticals Price Performance Shares of EPRX opened at $2.85 on Wednesday. Eupraxia Pharmaceuticals has a 12-month low of $2.48 and a 12-month high of $6.78. Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get […] ....

Raymond-james , Eupraxia-pharmaceuticals , Eupraxia-pharmaceuticals-inc , News-ratings-for-eupraxia-pharmaceuticals-daily , Eupraxia-pharmaceuticals-price-performance , Eupraxia-pharmaceuticals-company-profile , Free-report , Get-free-report , Pharmaceuticals-inc , Eupraxia-pharmaceuticals-daily ,

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Rating Upgraded by Raymond James

Raymond James upgraded shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) to a strong-buy rating in a research report released on Wednesday morning, Zacks.com reports. Eupraxia Pharmaceuticals Price Performance Eupraxia Pharmaceuticals stock opened at $2.85 on Wednesday. Eupraxia Pharmaceuticals has a 1-year low of $2.48 and a 1-year high of $6.78. Eupraxia Pharmaceuticals (NASDAQ:EPRX – […] ....

Raymond-james , News-ratings-for-eupraxia-pharmaceuticals-daily , Eupraxia-pharmaceuticals-price-performance , Eupraxia-pharmaceuticals-inc , Eupraxia-pharmaceuticals , Free-report , Get-free-report , Pharmaceuticals-inc , Eupraxia-pharmaceuticals-daily ,

Eupraxia Expands Trial for Promising EoE Therapy

Eupraxia Expands Trial for Promising EoE Therapy
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Eupraxia-pharmaceuticals ,